Mepyramine
{{short description|First generation antihistamine}}
{{Use dmy dates|date=April 2024}}
{{cs1 config|name-list-style=vanc|display-authors=6}}
{{Drugbox
| Verifiedfields = changed
| class = First-generation antihistamine
| verifiedrevid = 408591350
| IUPAC_name = N-(4-methoxybenzyl)-N
| image = Mepyramine.svg
| tradename =
| Drugs.com = {{drugs.com|international|mepyramine}}
| MedlinePlus = a606008
| pregnancy_category =
| legal_status = OTC
| routes_of_administration = By mouth, topical
| bioavailability =
| protein_bound =
| metabolism =
| elimination_half-life =
| excretion =
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 91-84-9
| CAS_supplemental =
{{CAS|59-33-6}} (maleate)
| ATC_prefix = R06
| ATC_suffix = AC01
| ATC_supplemental = {{ATC|D04|AA02}}
| PubChem = 4992
| IUPHAR_ligand = 1227
| DrugBank_Ref = {{drugbankcite|changed|drugbank}}
| DrugBank = DB06691
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 4818
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = HPE317O9TL
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D08183
| ChEBI_Ref = {{ebicite|changed|EBI}}
| ChEBI = 6762
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 511
| synonyms = Pyrilamine; N-[2-(dimethylamino)ethyl]-N-[(4-methoxyphenyl)methyl]pyridin-2-amine
| C = 17
| H = 23
| N = 3
| O = 1
| SMILES = O(c1ccc(cc1)CN(c2ncccc2)CCN(C)C)C
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C17H23N3O/c1-19(2)12-13-20(17-6-4-5-11-18-17)14-15-7-9-16(21-3)10-8-15/h4-11H,12-14H2,1-3H3
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = YECBIJXISLIIDS-UHFFFAOYSA-N
}}
Mepyramine, also known as pyrilamine, is a first-generation antihistamine, targeting the H1 receptor as an inverse agonist. Mepyramine rapidly permeates the brain, often causing drowsiness.
{{cite web
|url= https://go.drugbank.com/drugs/DB06691
|title =Mepyramine
|access-date = 8 May 2021
|website=drugbank.com
}}
It is often sold as a maleate salt, pyrilamine maleate.
The medication has negligible anticholinergic activity, with 130,000-fold selectivity for the histamine H1 receptor over the muscarinic acetylcholine receptors (for comparison, diphenhydramine had 20-fold selectivity for the H1 receptor).{{cite journal | vauthors = Kubo N, Shirakawa O, Kuno T, Tanaka C | title = Antimuscarinic effects of antihistamines: quantitative evaluation by receptor-binding assay | journal = Japanese Journal of Pharmacology | volume = 43 | issue = 3 | pages = 277–282 | date = March 1987 | pmid = 2884340 | doi = 10.1254/jjp.43.277 | doi-access = free }}
It was patented in 1943 and came into medical use in 1949.{{cite book | veditors = Fischer J, Gannelin CR |title=Analogue-based Drug Discovery |date=2006 |publisher=John Wiley & Sons |isbn=9783527607495 |page=545 |url=https://books.google.com/books?id=FjKfqkaKkAAC&pg=PA545 |language=en}}
It was marketed under the names Histadyl, Histalon, Neo-Antergan, Neo-Pyramine, and Nisaval.{{cite journal | vauthors = Thornton WE | title = Sleep aids and sedatives | journal = Journal of the American College of Emergency Physicians | volume = 6 | issue = 9 | pages = 408–412 | date = September 1977 | pmid = 330911 | doi = 10.1016/S0361-1124(77)80006-3 }} In the 1960s and 70s it was a very common component in over-the-counter sleep aids such as Alva-Tranquil, Dormin, Sedacaps, Sominex, Nytol, and many others. The US Food and Drug Administration (FDA) included it in the list of chemicals and compounds barred from use in over-the-counter (OTC) nighttime sleep aid products in 1989.{{Federal Register|54|6826}}
It is used in over-the-counter combination products to treat the common cold and menstrual symptoms such as Midol Complete.{{Cite web |url=http://midol.com/menstrual_complete_caps.html#q1 |title=Active Ingredients for Midol Complete |access-date=2009-12-08 |archive-url=https://web.archive.org/web/20091202030735/http://www.midol.com/menstrual_complete_caps.html#q1 |work=Bayer HealthCare LLC |archive-date=2009-12-02 |url-status=dead}} It is also the active ingredient of the topical antihistamine creams Anthisan{{Cite web |url=https://www.medicines.org.uk/emc/product/1618/pil |title=Anthisan Cream - Patient Information Leaflet (PIL) |website=Medicines.org}} and Neoantergan{{cite journal | vauthors = Parsons ME, Ganellin CR | title = Histamine and its receptors | journal = British Journal of Pharmacology | volume = 147 | issue = Suppl 1 | pages = S127–S135 | date = January 2006 | pmid = 16402096 | pmc = 1760721 | doi = 10.1038/sj.bjp.0706440 | publication-date = 2009-02-02 }} sold for the treatment of insect bites, stings, and nettle rash.
See also
References
{{Reflist}}
{{Antipruritics}}
{{Antihistamines}}
{{Hallucinogens}}
{{Navboxes
| title = Pharmacodynamics
| titlestyle = background:#ccccff
| list1 =
{{Histamine receptor modulators}}
{{Monoamine reuptake inhibitors}}
{{Sigma receptor modulators}}
}}
Category:H1 receptor antagonists
Category:Muscarinic antagonists
Category:4-Methoxyphenyl compounds